Effects of antiarrhythmic drug responsiveness and diagnosis-to-ablation time on outcomes after catheter ablation for persistent atrial fibrillation.
Hong-Ju KimDaehoon KimKipoong KimSung Hwa ChoiMoon-Hyun KimJe-Wook ParkHee Tae YuTae-Hoon KimJae Sun UhmBoyoung JoungMoon-Hyoung LeeHui Nam PakPublished in: Journal of arrhythmia (2024)
Both DAT and AAD responsiveness influenced AFCA rhythm outcomes. Delaying AFCA to a DAT of longer than 22 months was inadvisable, particularly in the participants in whom PeAF was changed to paroxysmal AF during AAD therapy.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- emergency department
- metabolic syndrome
- type diabetes
- coronary artery disease
- blood pressure
- skeletal muscle
- adverse drug
- acute coronary syndrome
- mesenchymal stem cells
- weight loss